GB2414400B — Injection device
Assigned to Cilag GmbH International · Expires 2009-01-14 · 17y expired
What this patent protects
An injection device (110) is described having a housing (112) and a cap (130). The injection device (110) houses a syringe (114) having a needle (118) which is sealed by a boot (120). The cap (130) is arranged so that the boot (120) can be connected to the cap (130) simply, but c…
USPTO Abstract
An injection device (110) is described having a housing (112) and a cap (130). The injection device (110) houses a syringe (114) having a needle (118) which is sealed by a boot (120). The cap (130) is arranged so that the boot (120) can be connected to the cap (130) simply, but cannot be removed from the cap (130). The housing (112) and cap (130) are arranged so that upon rotation of the cap (130), the cap (130) is moved axially away from the housing (112) and the boot (120) is removed from the syringe (114). The injection device is simple to use and manufacture.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.